Recombinant Human LRRC25 (C-6His)

Description

EnkiLife provides the Recombinant Human LRRC25 (C-6His) protein,aslo know as Leucine-rich repeat-containing protein 25,Monocyte and plasmacytoid-activated protein,MAPA,FLJ38116,UNQ6169/PRO20174, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Leucine-Rich Repeat-Containing Protein 25/Monocyte And Plasmacytoid-activated Protein is produced by our Mammalian expression system and the target gene encoding Leu21-Thr165 is expressed with a 6His tag at the C-terminus.Accession:Q8N386. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:16.7 KDa. Background:Leucine-rich repeat-containing protein 25(LRRC25) is a single-pass type I membrane protein and contains 3 LRR (leucine-rich) repeats. The protein expressed in plasmacytoid dendritic cells (PDC), monocyte-derived dendritic cells (MDDC), granulocytes, monocytes, B-lymphocytes, peripheral blood leukocytes, spleen, bone marrow, and, to a lesser extent, lymph nodes, fetal liver, and appendix but not in thymus. The protein may be involved in the activation of cells of innate and acquired immunity.